Department of Health and Human Services · Food and Drug Administration · FDA OFFICE OF ACQ GRANT SVCS
Account requiredWhy it scored this way
Every reason behind the verdict rather than the headline one — which of your certifications match, how much runway is left, whether the work is your size, and what we would need to know to sharpen it.
Written against this notice and what you have told us about your company. Anything we do not know is marked [NEEDS INPUT] in the draft rather than guessed at — read it before you send it.
Start a free trial to draft these. Nothing is sent to an agency on your behalf, ever — you get a document to review, edit and submit yourself.
Compliance matrix
Every stated and implied requirement, its source section, whether it is mandatory, and where your response will address it.
Proposal outline
A submission skeleton where every required element is a heading with its source requirement quoted beneath it. You write the substance; nothing gets forgotten.
Questions to submit
Genuine ambiguities and requirements that disadvantage a smaller bidder, drafted as questions you can submit before the Q&A deadline.
Past performance write-ups
Which of your prior awards best match this requirement, and draft write-ups in the format the agency asked for.
Solicitation details
Solicitation number
75F40126R00049
Notice type
Solicitation
NAICS
236220
Product service code
Z2DB
Set-aside
No Set aside used
Posted
2026-08-04
Response deadline
Aug 20, 2026, 4:00 PM UTC
Place of performance
Irvine, CA
Contracting contact
Sheneil.Green@fda.hhs.gov
Market intelligence
Account requiredWho wins this work, and what it pays
Comparable awards under NAICS 236220 at this agency — the incumbent, what they were paid, when their period of performance ends, and the real pricing distribution rather than the headline number. From public federal award records.
Amendment 0001 is issued to provide the Government's responses to questions received regarding the solicitation and to incorporate revisions to the applicable solicitation documents. Offerors are to review Amendment 0001 and all revised attachments/documents in their entirety and acknowledge receipt of the amendment in accordance with the solicitation instructions. The proposal due date is extended. Proposal Due Date: August 20, 2026, at 12:00 PM Eastern Time (ET) ****************************************************** The Mandatory Site Visit Attendee List is posted. Please refer to "75F40126R00049 Site Visit Attendee List 260722". ****************************************************** The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is issuing Solicitation 75F40126R00049 for the IRV Lab Exhaust & Vacuum Pump Replacement Project at the FDA Pacific Southwest Laboratory, 19701 Fairchild Road, Irvine, California. This is a full and open competition. The contractor shall provide all labor, materials, equipment, supervision, permits, testing, commissioning, and related services needed to remove and replace the laboratory vacuum pump system and install a new laboratory exhaust system. The work also includes Building Automation System (BAS) integration, testing and balancing (TAB), commissioning, training, and project closeout, as described in the solicitation and Scope of Work. Mandatory Site Visit: A mandatory site visit will be held on: Date: Wednesday, July 22, 2026 Time: 8:30 a.m. Pacific Time Location: FDA Pacific Southwest Laboratory, 19701 Fairchild Road, Irvine, CA 92612 To attend, offerors must register by 12:00 p.m. Pacific Time on Monday, July 20, 2026 by emailing the Contracting Officer and Contract Specialist listed in the solicitation. Include the names of all attendees when registering. Each company may send up to three (3) representatives. All attendees must present a valid government-issued photo ID and comply with FDA security requirements. Attendance at the site visit is required. The Government will not consider proposals from offerors that do not attend the mandatory site visit. No exceptions. Submit questions and proposals by the deadlines shown in the solicitation. The solicitation, attachments, and any amendments are available through this SAM.gov notice. Offerors must have an active registration in SAM.gov when they submit a proposal, during the evaluation period, and before contract award.
Contact
Point of contact
Sheneil Green
Role
not stated on this notice — SAM publishes a role for only about 5% of them, so this may be a contract specialist rather than the contracting officer
Email
Sheneil.Green@fda.hhs.gov
Secondary
Linda.Finan@fda.hhs.gov
Submit questions
Ambiguities and requirements worth clarifying, written as questions you can send before the deadline.
Opens in your own mail client, addressed and with a subject line — you write the message. GovSprint never sends anything on your behalf.
Emails open in your mail client and are sent from your address, so the reply comes back to you and the exchange stays yours. Confirm the correct channel and any question deadline on the notice before sending — many solicitations require questions in a specific way.
